In recent years progress has been made in developing cancer immunotherapies that target specific aspects of an individual’s tumour.more
Introducing cancer immunotherapy
Immunotherapy at Roche
Roche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.more
Beyond the immunity cycle
Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.
Collaboration in research
Cancer remains one of the leading causes of death worldwide, but world-class research provides hope.more
Discover Roche’s latest innovations in cancer immunotherapy
Roche scientists discuss their work at the cutting edge of cancer immunotherapy researchmore
CEO on cancer immunotherapy
Roche CEO Severin Schwan talks about our commitment and leadership in this exciting field.
Rewriting the book on immunotherapy
Learn how biomarkers take the stage in helping doctors diagnose cancer.more
Linking T-cells and cancer cells
When the body’s own immune system fails, T-cell bispecific antibodies help T-cells spring back into action and attack cancer cells.
Unleashing the T-Cell army
Learn how our research and development team managed to separate 200 known cancer types into three primary immune profiles.
The PD-L1 pathway
The role of the immune system is to protect the body from foreign invaders. PD-L1 can help tumour cells evade the immune surveillance.